EMD Serono强调了其致力于推进创新癌症治疗的承诺，旨在将更多癌症患者转变为康复者。该公司的研究努力集中在创建差异化分子以靶向癌症的弱点，努力满足具有挑战性癌症类型患者的需求。凭借59%的强劲毛利率和来自 InvestingPro ...

Since taking over drug firm Serono in 1996 from his father, Bertarelli has built it into Europe's biggest biotech. A public offering in 2000 netted $2 billion; Serono's market capitalization rose ...

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced new research from the company’s diverse oncology ...

BEIJING - Merck Serono Co Ltd, the biopharmaceutical division of Merck KGaA, will pursue stratified treatment research and development (R&D) in China, with the drug company's fourth R&D facility ...

ROCKLAND, Mass.--(BUSINESS WIRE)--EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, announced today that the Phase III CENTRIC a trial of the investigational integrin inhibitor ...

Serono aims to boost annual sales by 20 per cent a year and is looking for small acquisitions, chief executive Erneston Bertarelli said. Bertarelli told the Swiss business newspaper HandelsZeitung ...

Novartis, Switzerland's largest drug maker, was at one stage seen as a front-runner to acquire Serono while Britain's AstraZeneca as well as the US drug makers Pfizer, Johnson & Johnson and Wyeth ...

Article ‘Count’ and ‘Share’ for Merck Serono S.A. based on listed parameters only. The articles listed below published by authors from Merck Serono S.A., organized by journal and article ...

EMD Serono's new advertising campaign for its infertility treatment uses an unusual tactic for the drug industry: jokes. Most pharmaceutical ads are about diseases, and patients generally want ...

So Lebson extended her post-doc research work into oncology as well. Previously, Lebson’s role focused on EMD Serono’s MS portfolio. It now includes oncology and fertility drugs as well.